PT - JOURNAL ARTICLE AU - Chen, Sida AU - Marshall, Tom AU - Jackson, Christopher AU - Cooper, Jennifer AU - Crowe, Francesca AU - Nirantharakumar, Krish AU - Saunders, Catherine L AU - Kirk, Paul AU - Richardson, Sylvia AU - Edwards, Duncan AU - Griffin, Simon AU - Yau, Christopher AU - Barrett, Jessica K TI - Sociodemographic Characteristics and Longitudinal Progression of Multimorbidity: A Multistate Modelling Analysis of a Large Primary Care Records Dataset in England AID - 10.1101/2023.03.06.23286491 DP - 2023 Jan 01 TA - medRxiv PG - 2023.03.06.23286491 4099 - http://medrxiv.org/content/early/2023/10/02/2023.03.06.23286491.short 4100 - http://medrxiv.org/content/early/2023/10/02/2023.03.06.23286491.full AB - Background Multimorbidity, characterized by the coexistence of multiple chronic conditions in an individual, is a rising public health concern. While much of the existing research has focused on cross-sectional patterns of multimorbidity, there remains a need to better understand the longitudinal accumulation of diseases. This includes examining the associations between important sociodemographic characteristics and the rate of progression of chronic conditions.Methods and findings We utilized electronic primary care records from 13 million participants in England, drawn from the Clinical Practice Research Datalink (CPRD Aurum), spanning from 2005 to 2020 with a median follow-up of 4.71 years (IQR: 1.78, 11.28). The study focused on five important chronic conditions: cardiovascular disease, type-2 diabetes, chronic kidney disease, heart failure and mental health conditions. Key sociodemographic characteristics considered include ethnicity, social and material deprivation, gender, and age. We employed a flexible spline-based parametric multistate model to investigate the associations between these sociodemographic characteristics and the rate of different disease transitions throughout multimorbidity development. Our findings reveal distinct association patterns across different disease transition types.Deprivation, gender and age generally demonstrated stronger associations with disease diagnosis compared to ethnic group differences. Notably, the impact of these factors tended to attenuate with an increase in the number of pre-existing conditions, especially for deprivation, gender and age. Furthermore, the impact of deprivation, gender, and age was typically more pronounced when transitioning from a mental health condition. A primary limitation of our study is that potential diagnostic inaccuracies in primary care records, such as underdiagnosis, overdiagnosis, or ascertainment bias of chronic conditions, could influence our results.Conclusion Our results indicate that early phases of multimorbidity development could warrant increased attention. The potential importance of earlier detection and intervention of chronic conditions is underscored, particularly for mental health conditions and higher-risk populations. These insights may have important implications for the management of multimorbidity.Why Was This Study Done?Multimorbidity, the presence of two or more chronic conditions in an individual, is a growing concern in aging societies. A better understanding of how these conditions develop and progress over time, and the factors associated with this process, is important for more effective management and treatment.Previous research has analysed the association between certain socioeconomic and behavioural factors and the rate of disease progression over time. However, these studies typically focused on a limited number of conditions and rarely considered all possible combinations. Furthermore, their analyses often rely on relatively small datasets.There is a gap in our detailed understanding of the impact of sociodemographic characteristics – such as ethnicity, deprivation, age, and gender - on the progression of multiple chronic conditions.What Did the Researchers Do and Find?We analysed the health records of over 13 million participants in England from 2005 to 2020, focusing on how factors like ethnicity, deprivation, gender and age are associated with the accumulation of five common conditions: cardiovascular disease (CVD), type-2 diabetes (T2D), chronic kidney disease (CKD), heart failure (HF), and mental health conditions (MH).We found that factors like deprivation, age, and gender generally have a stronger link to the diagnosis of these conditions compared to ethnicity. Moreover, the impact of deprivation, age and gender tend to be weakened as the number of pre-existing conditions a person has increases.In particular, when an individual already has a mental health condition, and if they were older, male, or from more deprived groups, they were expected to develop other conditions like CVD, T2D and HF more quickly compared to scenarios involving other pre-existing conditions.What Do These Findings Mean?ur findings suggest that early stages, when people are starting to develop multiple health issues, especially when mental health problems are first diagnosed and in high-risk groups, may require more attention for improved patient care and healthcare strategies.ur results underscore the need to investigate and better understand the different biological, psychological, and societal factors that influence the progression to multimorbidity.that our analysis is based on health records, which may have incomplete or inaccurate information, including potential inaccuracies in condition diagnosis. These limitations may have an influence on our results.Competing Interest StatementJB has previously received funding for unrelated work from F. Hoffmann-La Roche Ltd. KN reports grants from NIHR, MRC, Diabetes UK, Vifor, and AstraZeneca, and personal fees from Merck Sharp & Dohme, Sanofi, and Boehringer Ingelheim, outside of and unrelated to the submitted work. TM has previously received funding for unrelated work: from Cancer Research UK and from the Health Research Board (Ireland) for advisory board participation and travel. SJG received payment from Novo Nordisk, Napp and Astra Zeneca for lectures at 6 educational events over the last 3 years. Napp supported SJG's attendance at EASD 2018 and he received payment from Eli Lilly associated with membership of an independent data monitoring committee for a randomised trial of a medication to lower glucose. PK, SR and KN are co-investigators on the HDRUK grant titled Measuring & Understanding Multimorbidity using Routine Data in the UK (MUrMuR-UK). CY has received remuneration for unrelated consultancy services to F. Hoffmann-La Roche and Singula Bio. The remaining authors have no conflicts of interest. Funding StatementThis work is funded by the MRC/NIHR grant MR/S027602/1 (BIRM-CAM). TM is supported by the National Institute for Health Research Collaboration Applied Research Collaboration West Midlands (NIHR ARC WM). KN is funded by a Health Data Research UK Fellowship. CY is funded by a UKRI Turing AI Fellowship (EP/V023233/2). JB was funded by MRC unit programme MC_UU_00002/5. CJ was funded by the Medical Research Council programme number MRC_MC_UU_00002/11. PK was funded by MRC unit programme MC_UU_00002/13. SR was funded by MRC unit programme MC_UU_00002/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Clinical Practice Research Datalink (CPRD) Research Database has ethics approval from the Health Research Authority to support research using anonymised patient data (East Midlands - Derby Research Ethics Committee, reference 21/EM/0265). Data was approved for this study by the CPRD Independent Scientific Advisory Committee (protocol 19_265).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data were provided under license by the Clinical Practice Research Datalink (CPRD), and so are not publicly available. Access to CPRD data is subject to protocol approval via CPRD's Research Data Governance (RDG) Process.